Email Us
View Reports

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Report 2018

  • ID : 5667208  |  
  • Published : Apr-2018  |  
  • Region : Global  |  
  • Pages : 113   |  
  • Publisher : QY Research

In this report, the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of B-Cell Maturation Antigen(BCMA) Targeted Therapies for these regions, from 2013 to 2025 (forecast), covering

United States

China

Europe

Japan

Southeast Asia

India

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies market competition by top manufacturers/players, with B-Cell Maturation Antigen(BCMA) Targeted Therapies sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

Transposagen Biopharmaceuticals

Sutro Biopharma

Malin Corporation

Eureka Therapeutics

firstVentury Equity

Five Prime Therapeutics

Credit Suisse Securities

Dana-Farber Cancer Institute

Deerfield Partners

Onyx Pharmaceuticals

Juno Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Bispecific Antibodies

Antibody Drug Conjugates

Chimeric Antigen Receptor T-Cells

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Liver Cancer

Respiratory Cancer

Brain Cancer

Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Report 2018

1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview

1.1 Product Overview and Scope of B-Cell Maturation Antigen(BCMA) Targeted Therapies

1.2 Classification of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Product Category

1.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Sales) Comparison by Type (2013-2025)

1.2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Sales) Market Share by Type (Product Category) in 2017

1.2.3 Bispecific Antibodies

1.2.4 Antibody Drug Conjugates

1.2.5 Chimeric Antigen Receptor T-Cells

1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Application/End Users

1.3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (Volume) and Market Share Comparison by Application (2013-2025)

1.3.2 Liver Cancer

1.3.3 Respiratory Cancer

1.3.4 Brain Cancer

1.3.5 Others

1.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Region

1.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Value) Comparison by Region (2013-2025)

1.4.2 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2013-2025)

1.4.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2013-2025)

1.4.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2013-2025)

1.4.5 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2013-2025)

1.4.6 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2013-2025)

1.4.7 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2013-2025)

1.5 Global Market Size (Value and Volume) of B-Cell Maturation Antigen(BCMA) Targeted Therapies (2013-2025)

1.5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2013-2025)

1.5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2013-2025)

2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Competition by Players/Suppliers, Type and Application

2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Competition by Players/Suppliers

2.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Market Share of Key Players/Suppliers (2013-2018)

2.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Share by Players/Suppliers (2013-2018)

2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume and Value) by Type

2.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Market Share by Type (2013-2018)

2.2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Market Share by Type (2013-2018)

2.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume and Value) by Region

2.3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Market Share by Region (2013-2018)

2.3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Market Share by Region (2013-2018)

2.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume) by Application

3 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)

3.1 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2013-2018)

3.1.1 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2013-2018)

3.1.2 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2013-2018)

3.1.3 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2013-2018)

3.2 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players (2013-2018)

3.3 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type (2013-2018)

3.4 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application (2013-2018)

4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)

4.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2013-2018)

4.1.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2013-2018)

4.1.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2013-2018)

4.1.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2013-2018)

4.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players (2013-2018)

4.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type (2013-2018)

4.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application (2013-2018)

5 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)

5.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2013-2018)

5.1.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2013-2018)

5.1.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2013-2018)

5.1.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2013-2018)

5.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players (2013-2018)

5.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type (2013-2018)

5.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application (2013-2018)

6 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)

6.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2013-2018)

6.1.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2013-2018)

6.1.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2013-2018)

6.1.3 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2013-2018)

6.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players (2013-2018)

6.3 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type (2013-2018)

6.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)

7.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2013-2018)

7.1.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2013-2018)

7.1.2 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2013-2018)

7.1.3 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2013-2018)

7.2 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players (2013-2018)

7.3 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type (2013-2018)

7.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application (2013-2018)

8 India B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)

8.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2013-2018)

8.1.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2013-2018)

8.1.2 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2013-2018)

8.1.3 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2013-2018)

8.2 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players (2013-2018)

8.3 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type (2013-2018)

8.4 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application (2013-2018)

9 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Players/Suppliers Profiles and Sales Data

9.1 Transposagen Biopharmaceuticals

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.1.4 Main Business/Business Overview

9.2 Sutro Biopharma

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.2.4 Main Business/Business Overview

9.3 Malin Corporation

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.3.4 Main Business/Business Overview

9.4 Eureka Therapeutics

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.4.4 Main Business/Business Overview

9.5 firstVentury Equity

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.5.4 Main Business/Business Overview

9.6 Five Prime Therapeutics

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.6.4 Main Business/Business Overview

9.7 Credit Suisse Securities

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.7.4 Main Business/Business Overview

9.8 Dana-Farber Cancer Institute

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.8.4 Main Business/Business Overview

9.9 Deerfield Partners

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.9.4 Main Business/Business Overview

9.10 Onyx Pharmaceuticals

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2013-2018)

9.10.4 Main Business/Business Overview

9.11 Juno Therapeutics

10 B-Cell Maturation Antigen(BCMA) Targeted Therapies Maufacturing Cost Analysis

10.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies

10.3 Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2017

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast (2018-2025)

14.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue and Price Forecast (2018-2025)

14.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate Forecast (2018-2025)

14.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate Forecast (2018-2025)

14.1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Price and Trend Forecast (2018-2025)

14.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)

14.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate Forecast by Regions (2018-2025)

14.2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate Forecast by Regions (2018-2025)

14.2.3 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.5 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.6 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.7 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.2.8 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue and Growth Rate Forecast (2018-2025)

14.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue and Price Forecast by Type (2018-2025)

14.3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Forecast by Type (2018-2025)

14.3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Forecast by Type (2018-2025)

14.3.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Price Forecast by Type (2018-2025)

14.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology/Research Approach

16.1.1 Research Programs/Design

16.1.2 Market Size Estimation

16.1.3 Market Breakdown and Data Triangulation

16.2 Data Source

16.2.1 Secondary Sources

16.2.2 Primary Sources

16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of B-Cell Maturation Antigen(BCMA) Targeted Therapies

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Comparison (K Units) by Type (2013-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type (Product Category) in 2017

Figure Bispecific Antibodies Product Picture

Figure Antibody Drug Conjugates Product Picture

Figure Chimeric Antigen Receptor T-Cells Product Picture

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Comparison (K Units) by Application (2013-2025)

Figure Global Sales Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application in 2017

Figure Liver Cancer Examples

Table Key Downstream Customer in Liver Cancer

Figure Respiratory Cancer Examples

Table Key Downstream Customer in Respiratory Cancer

Figure Brain Cancer Examples

Table Key Downstream Customer in Brain Cancer

Figure Others Examples

Table Key Downstream Customer in Others

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) by Regions (2013-2025)

Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2025)

Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2025)

Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2025)

Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2025)

Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Growth Rate (2013-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2025)

Figure Global Market Major Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) of Key Players/Suppliers (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share by Players/Suppliers (2013-2018)

Figure 2017 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share by Players/Suppliers

Figure 2017 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share by Players/Suppliers

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) by Players/Suppliers (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) by Players/Suppliers (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Players/Suppliers (2013-2018)

Table 2017 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Players

Table 2017 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Players

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) and Market Share by Type (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share (K Units) by Type (2013-2018)

Figure Sales Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type (2013-2018)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate by Type (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Market Share by Type (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type (2013-2018)

Figure Revenue Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type (2013-2018)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate by Type (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Market Share by Region (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share by Region (2013-2018)

Figure Sales Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Region (2013-2018)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate by Region in 2017

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Market Share by Region (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share (%) by Region (2013-2018)

Figure Revenue Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Region (2013-2018)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate by Region in 2017

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Market Share by Region (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share (%) by Region (2013-2018)

Figure Revenue Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Region (2013-2018)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Region in 2017

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Market Share by Application (2013-2018)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share (%) by Application (2013-2018)

Figure Sales Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application (2013-2018)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Application (2013-2018)

Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) and Growth Rate (2013-2018)

Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2018)

Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) Trend (2013-2018)

Table United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Players (2013-2018)

Table United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players (2013-2018)

Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players in 2017

Table United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Type (2013-2018)

Table United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type (2013-2018)

Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type in 2017

Table United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Application (2013-2018)

Table United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application (2013-2018)

Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application in 2017

Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) and Growth Rate (2013-2018)

Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2018)

Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) Trend (2013-2018)

Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Players (2013-2018)

Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players (2013-2018)

Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players in 2017

Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Type (2013-2018)

Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type (2013-2018)

Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type in 2017

Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Application (2013-2018)

Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application (2013-2018)

Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application in 2017

Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) and Growth Rate (2013-2018)

Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2018)

Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) Trend (2013-2018)

Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Players (2013-2018)

Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players (2013-2018)

Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players in 2017

Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Type (2013-2018)

Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type (2013-2018)

Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type in 2017

Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Application (2013-2018)

Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application (2013-2018)

Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application in 2017

Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) and Growth Rate (2013-2018)

Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2018)

Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) Trend (2013-2018)

Table Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Players (2013-2018)

Table Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players (2013-2018)

Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players in 2017

Table Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Type (2013-2018)

Table Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type (2013-2018)

Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type in 2017

Table Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Application (2013-2018)

Table Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application (2013-2018)

Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application in 2017

Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) and Growth Rate (2013-2018)

Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2018)

Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) Trend (2013-2018)

Table Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Players (2013-2018)

Table Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players (2013-2018)

Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players in 2017

Table Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Type (2013-2018)

Table Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type (2013-2018)

Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type in 2017

Table Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Application (2013-2018)

Table Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application (2013-2018)

Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application in 2017

Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) and Growth Rate (2013-2018)

Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate (2013-2018)

Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) Trend (2013-2018)

Table India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Players (2013-2018)

Table India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players (2013-2018)

Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Players in 2017

Table India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Type (2013-2018)

Table India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type (2013-2018)

Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Type in 2017

Table India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) by Application (2013-2018)

Table India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application (2013-2018)

Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share by Application in 2017

Table Transposagen Biopharmaceuticals Basic Information List

Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018)

Figure Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table Sutro Biopharma Basic Information List

Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018)

Figure Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table Malin Corporation Basic Information List

Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018

Figure Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table Eureka Therapeutics Basic Information List

Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018)

Figure Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table firstVentury Equity Basic Information List

Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018)

Figure firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table Five Prime Therapeutics Basic Information List

Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018

Figure Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table Credit Suisse Securities Basic Information List

Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018)

Figure Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table Dana-Farber Cancer Institute Basic Information List

Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018

Figure Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table Deerfield Partners Basic Information List

Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018)

Figure Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table Onyx Pharmaceuticals Basic Information List

Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2013-2018)

Figure Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Global Market Share (2013-2018)

Figure Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Global Market Share (2013-2018)

Table Juno Therapeutics Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of B-Cell Maturation Antigen(BCMA) Targeted Therapies

Figure Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies

Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Industrial Chain Analysis

Table Raw Materials Sources of B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Players in 2017

Table Major Buyers of B-Cell Maturation Antigen(BCMA) Targeted Therapies

Table Distributors/Traders List

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Price (USD/Unit) and Trend Forecast (2018-2025)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) Forecast by Regions (2018-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share Forecast by Regions (2018-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share Forecast by Regions in 2025

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) Forecast by Regions (2018-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share Forecast by Regions (2018-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share Forecast by Regions in 2025

Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate Forecast (2018-2025)

Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) Forecast by Type (2018-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Market Share Forecast by Type (2018-2025)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) Forecast by Type (2018-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share Forecast by Type (2018-2025)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Price (USD/Unit) Forecast by Type (2018-2025)

Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) Forecast by Application (2018-2025)

Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?